Short answer · Medically reviewed summary · Last updated: 2026-04-07
Mitochondrial Myopathy is a broad clinical term used to describe a group of neuromuscular disorders caused by genetic mutations that impair the function of mitochondria, and it is frequently referred to by synonyms such as mitochondrial encephalomyopathy or, more specifically, by the names of individual syndromes like Kearns-Sayre syndrome or MELAS. Common Synonyms and Historical Nomenclature Because Mitochondrial Myopathy encompasses a wide spectrum of disorders, you may encounter several terms depending on the specific clinical presentation. Historical literature often uses the term "mitochondrial cytopathy" or "mitochondrial disease" interchangeably.
Mitochondrial Myopathy synonyms
Other names for Mitochondrial Myopathy: synonyms, acronyms and related terms used by doctors and patients.
Mitochondrial Myopathy is a broad clinical term used to describe a group of neuromuscular disorders caused by genetic mutations that impair the function of mitochondria, and it is frequently referred to by synonyms such as mitochondrial encephalomyopathy or, more specifically, by the names of individual syndromes like Kearns-Sayre syndrome or MELAS.
Common Synonyms and Historical Nomenclature
Because Mitochondrial Myopathy encompasses a wide spectrum of disorders, you may encounter several terms depending on the specific clinical presentation. Historical literature often uses the term "mitochondrial cytopathy" or "mitochondrial disease" interchangeably. In older medical records, you might see the condition referred to as "ragged-red fiber disease," a name derived from the characteristic appearance of muscle biopsy samples under a microscope. Depending on the specific genetic mutation, you may also see names like CPEO (Chronic Progressive External Ophthalmoplegia) or MERRF (Myoclonic Epilepsy with Ragged-Red Fibers), which are specific sub-types of Mitochondrial Myopathy.
Official Classifications and Why Names Vary
The naming of Mitochondrial Myopathy has evolved alongside our understanding of genetics. In the International Classification of Diseases (ICD-10/11), these conditions are often categorized under disorders of oxidative phosphorylation. The Online Mendelian Inheritance in Man (OMIM) database lists these conditions under specific genetic loci, while Orphanet (ORPHA:584) provides a structured classification that helps clinicians distinguish between isolated myopathies and multisystemic syndromes. The proliferation of names exists primarily because the field transitioned from naming diseases based on physical symptoms (like muscle weakness) to naming them based on the underlying molecular or mitochondrial DNA defect.
Preferred Clinical Terminology
Today, medical professionals prefer the term Mitochondrial Myopathy when the primary clinical feature is muscle weakness or exercise intolerance. However, if the disease affects multiple organ systems, clinicians will typically use the more comprehensive term "mitochondrial disease" or the specific syndrome name (e.g., MELAS or Leigh Syndrome). Understanding these synonyms is vital for navigating your medical records and ensuring consistency when consulting with different specialists.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- Orphanet: Mitochondrial myopathy (ORPHA:584)
- NIH Genetic and Rare Diseases Information Center (GARD): Mitochondrial myopathy
- Online Mendelian Inheritance in Man (OMIM): Mitochondrial Myopathy entry
